8.4 Hepatic Failure, Biliary Atresia, and Cholestasis
Key Takeaways
- Fractionate every concerning bilirubin: conjugated (direct) hyperbilirubinemia is pathologic and starts a cholestasis workup; unconjugated management and kernicterus prevention are taught in chapter 13.
- Biliary atresia presents with persistent jaundice, dark urine, and acholic (pale) stools; Kasai portoenterostomy works best when performed early, with clearly better bile-flow odds before 60 days of life than after 90 days.
- Prolonged parenteral nutrition without enteral stimulation is a major NICU cause of conjugated hyperbilirubinemia (intestinal failure–associated liver disease).
- Hepatic synthetic failure shows up as hypoglycemia, coagulopathy that does not correct with vitamin K alone when factor production has collapsed, hypoalbuminemia, and rising ammonia.
- Portal hypertension produces splenomegaly, ascites, and variceal risk; nursing care is bleeding precautions, glucose protection, and avoiding delays in the conjugated-bilirubin workup.
8.4 Hepatic Failure, Biliary Atresia, and Cholestasis
Quick Answer: A high conjugated (direct) bilirubin is never physiologic. Look at stool color, urine color, and whether the infant is still on parenteral nutrition. Acholic stools plus conjugated hyperbilirubinemia mean biliary atresia until the workup says otherwise, and the Kasai clock is measured in weeks, not months. Acute liver failure in the NICU shows up as hypoglycemia, bleeding, and encephalopathy as much as a rising bilirubin.
Hepatic failure is the GI leaf that overlaps bilirubin, nutrition, and coagulopathy. Independent OpenExamPrep teaching keeps one bright line: unconjugated hyperbilirubinemia (physiologic jaundice, hemolysis, dehydration, inadequate intake) is managed with phototherapy, hydration, and hemolysis workup in chapter 13. This section owns conjugated hyperbilirubinemia, extrahepatic obstruction, PN-associated cholestasis, and the neonate whose liver can no longer make glucose, clotting factors, and urea-cycle products.
Conjugated versus unconjugated: what the NICU nurse must split
Bilirubin from heme breakdown is unconjugated and albumin-bound until hepatocytes conjugate it with glucuronic acid for biliary excretion. Unconjugated (indirect) elevations threaten the brain (acute bilirubin encephalopathy) and are a phototherapy problem. Conjugated (direct) elevations mean bilirubin that has been processed by the hepatocyte cannot leave in bile, or hepatocytes are injured so conjugated pigment regurgitates into blood. A commonly used action threshold is a direct or conjugated bilirubin around ≥1 mg/dL (or above the laboratory's validated cutoff), especially if it persists or rises after the second week of life. That value is pathologic even if the total bilirubin does not look dramatic.
Clinical clues to cholestasis: jaundice that is still obvious after 2 weeks in a term infant, dark urine that stains, and acholic stools that are pale, gray, or clay-colored because stercobilin never formed in the gut. Stool color cards exist because parents and staff normalize pale stools. Ask to see a diaper; do not accept a chart that says seedy mustard if you have not looked. Absence of acholic stools does not exclude biliary atresia early, which is why fractionated bilirubin on the persistent-jaundice infant matters even when stools still have some pigment.
Biliary atresia and the Kasai clock
Biliary atresia is progressive fibro-inflammatory obliteration of extrahepatic (and often intrahepatic) bile ducts. Incidence is on the order of 1 in 8,000–18,000 live births. Infants may look well in the first weeks, which is why diagnosis is still often late. Untreated, the disease proceeds to cirrhosis, portal hypertension, and liver failure; it is a leading indication for pediatric liver transplant.
Nursing and team actions once conjugated hyperbilirubinemia is confirmed: consult pediatric gastroenterology/surgery without waiting for a complete academic workup in the birth hospital; check coagulation, glucose, albumin, and transaminases; obtain ultrasound (gallbladder may be small or absent; the triangular cord sign may be present, but a normal ultrasound does not stop the referral). Hepatobiliary scintigraphy after phenobarbital priming can show whether tracer reaches the intestine; liver biopsy and intraoperative cholangiogram complete the diagnosis in surgical centers. Evaluate for other cholestatic diseases (alpha-1 antitrypsin, Alagille, infection, hypothyroidism, metabolic disease) in parallel so treatable mimics are not missed, but do not let a long differential paralyze the biliary atresia pathway.
Kasai hepatic portoenterostomy resects atretic extrahepatic ducts and anastomoses a Roux-en-Y jejunal loop to the hepatic plate so bile can drain. Bile-flow success is strongly age-dependent. Teaching numbers used in pediatric hepatology: if portoenterostomy is performed within the first 60 days, a large fraction of infants (on the order of 70% in classic series) establish bile flow; after 90 days, bile-flow rates fall below 25%. Native-liver survival also declines as age at surgery moves from under 45 days toward 90 days. Newer primary-care guidance pushes identification by 2–4 weeks so Kasai can occur even earlier (ideally before 30–45 days). For the CCRN Neonatal exam, remember: pale stools and conjugated bilirubin are time-critical, and delayed Kasai is not a cosmetic delay. Postoperative cholangitis is common; families learn fever plus acholic relapse as an emergency. Many children still need transplant even after a technically successful Kasai; nursing honesty includes that possibility without stripping hope from early surgery.
TPN cholestasis and other NICU cholestatic injuries
Intestinal failure–associated liver disease (IFALD), still often called TPN cholestasis, appears in infants who receive prolonged PN, especially with little or no enteral feeding, recurrent sepsis, and short-gut anatomy. Soy-oil lipid minimization or mixed-lipid emulsions, cycling of PN, infection prevention, and any safe enteral stimulation are the treatments you can influence. Ursodeoxycholic acid is used in some protocols. The liver enzyme pattern is conjugated hyperbilirubinemia with a rising GGT or ALP more than a huge ALT at first. This is why trophic feeds in section 8.3 are also a liver therapy.
Other cholestatic hits in the NICU: urinary-tract infection and sepsis, parenteral antibiotic effects, cystic fibrosis meconium ileus physiology, hypothyroidism, pituitary-adrenal failure, and inborn errors (galactosemia, tyrosinemia, mitochondrial disease). A crashing cholestatic neonate needs glucose, coagulation support, and a metabolic screen, not only an ultrasound slot next Tuesday.
Portal hypertension, coagulopathy, and hypoglycemia
When fibrosis raises pressure in the portal vein, blood finds collaterals. Portal hypertension in infants shows splenomegaly (and hypersplenism with thrombocytopenia), ascites, dilated abdominal veins, and, later, esophageal or gastric varices. Nursing implications: avoid trauma to a distended abdomen, watch stool and emesis for blood, use nasogastric tubes with care if varices are known, and treat tense ascites as a respiratory as well as a fluid problem. Volume resuscitation in bleeding varices follows shock principles while hepatology prepares endoscopy or transplant pathways; do not attribute hematemesis only to reflux in a cirrhotic infant.
Coagulopathy of liver disease mixes vitamin K–dependent factor deficiency (cholestasis prevents bile-dependent vitamin K absorption) with true synthetic failure. Give vitamin K. If INR remains prolonged after vitamin K, the hepatocyte is not making factors; that infant needs plasma for active bleeding or invasive procedures, and the team should be talking about transplant evaluation, not another round of observation. Do not intramuscular-inject large volumes into a profoundly coagulopathic muscle if intravenous vitamin K is the safer route. Factor VII and fibrinogen trends help distinguish DIC from liver failure when both are on the differential after NEC or sepsis (chapter 7 and chapter 14).
Hypoglycemia in hepatic failure is a glycogen and gluconeogenesis failure. These infants cannot fast. Maintain a continuous glucose infusion, check bedside glucose with every change in infusion or feeding, and treat values with the same urgency you would in an infant of a diabetic mother (cross-link chapter 13 for IDM-specific teaching). Hyperammonemia and fluctuating tone suggest encephalopathy; protein intake, infection, and GI bleeding (a nitrogen load) can precipitate it.
Acute neonatal liver failure also includes viral hepatitis (HSV is an emergency), gestational alloimmune liver disease / neonatal hemochromatosis, and ischemic hepatitis after shock. HSV liver failure is a reminder to think infection when transaminases are extreme and coagulopathy is out of proportion; acyclovir decisions belong with the sepsis chapter but the liver is the organ failing in front of you.
Worked scenario and traps
A 22-day-old former 36-week infant is still jaundiced. Stools on the diaper are putty-colored. Direct bilirubin is 2.4 mg/dL. The wrong plan is another week of phototherapy for physiologic jaundice. The right plan is urgent cholestasis evaluation and surgical/GI referral aimed at a Kasai well before 60 days. Phototherapy treats unconjugated pigment; it does not open atretic ducts.
A gastroschisis survivor on week 6 of PN with no enteral feeds develops a rising direct bilirubin. Add a gut-use plan and lipid/infection review, not only ursodiol as a sticker on an otherwise unchanged PN prescription.
A 3-week-old still-jaundiced neonate has a rising direct bilirubin. Stools have not been inspected. Which action is correct?
Which statement about biliary atresia timing is the best CCRN Neonatal teaching point?
An infant with acute hepatic failure is due for a fasting imaging study. Which complication cluster should drive the nurse's NPO plan?